Analystreport

PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target lowered by analysts at Morgan Stanley from $47.00 to $31.00.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com